News

Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key role in the inflammatory response in plaque psoriasis.
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...
Driven by expensive drugs, hospital stays and growing behavioral health needs, healthcare spending is expected to keep rising ...
A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...
Switching to extended half-life therapies for hemophilia enhances treatment adherence and reduces infusion frequency, despite ...
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...
CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...
H. pylori infection significantly contributes to stomach cancer risk, but effective screening and treatment can prevent ...
This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...
Mulugeta Gebregziabher, Ph.D., spoke with Managed Healthcare Executive ahead of his presentation at IAS 2025 in Kigali, ...
The high cost of pharmaceutical products coupled with a lack of federally funded HIV programs create barriers for preexposure ...